1. Home
  2. Labeler Index
  3. Medvantx, Inc.
  4. 66116-407
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Gabapentin NDC 66116-407 by Medvantx, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - 38d9d7d7 9f81 4517 acee e34232215800 01

Chemical Structure - 38d9d7d7 9f81 4517 acee e34232215800 01

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - 38d9d7d7 9f81 4517 acee e34232215800 02

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - 38d9d7d7 9f81 4517 acee e34232215800 02

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - 38d9d7d7 9f81 4517 acee e34232215800 03

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - 38d9d7d7 9f81 4517 acee e34232215800 03

This is a study report showing the mean pain score over a period of 7 weeks. The study involved a 3-week dose titration period followed by a fixed dose period. The study included a placebo group and two groups receiving Gabapentin at doses of 1800 mg/day and 2400 mg/day. The mean pain scores were significantly lower for the Gabapentin groups than for the placebo group (p<0.01).*

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - 38d9d7d7 9f81 4517 acee e34232215800 04

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - 38d9d7d7 9f81 4517 acee e34232215800 04

The text provides statistical results related to the percentage of responders at endpoint for two studies. One of the studies shows a p-value of less than 0.001 and the other shows a p-value of less than 0.0001. No further information or context is provided.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study - 38d9d7d7 9f81 4517 acee e34232215800 05

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study - 38d9d7d7 9f81 4517 acee e34232215800 05

gabapentin 300mg 60 capsules - 38d9d7d7 9f81 4517 acee e34232215800 06

gabapentin 300mg 60 capsules - 38d9d7d7 9f81 4517 acee e34232215800 06

This is a medication label for Gabapentin capsules, USP. The dosage information is in the package insert. The medication should be taken every few hours and should not be allowed to run out. The capsules are 300mg and the lot number is 00000000. The expiration date is not stated. Storage should be at 20°-25°C (68°-77°F), and the container should be kept tightly closed. The label includes the contact details for Medvant and advises to keep the medication out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.